IT1286663B1 - PROTEIN CAPABLE OF INHIBITING RIBOSOMIAL ACTIVITY, ITS PREPARATION AND USE AS A CHEMICAL OR RECOMBINANT IMMUNOCONUGATE AND SEQUENCE OF CDNA - Google Patents
PROTEIN CAPABLE OF INHIBITING RIBOSOMIAL ACTIVITY, ITS PREPARATION AND USE AS A CHEMICAL OR RECOMBINANT IMMUNOCONUGATE AND SEQUENCE OF CDNAInfo
- Publication number
- IT1286663B1 IT1286663B1 IT96FI000155A ITFI960155A IT1286663B1 IT 1286663 B1 IT1286663 B1 IT 1286663B1 IT 96FI000155 A IT96FI000155 A IT 96FI000155A IT FI960155 A ITFI960155 A IT FI960155A IT 1286663 B1 IT1286663 B1 IT 1286663B1
- Authority
- IT
- Italy
- Prior art keywords
- ribosomial
- immunoconugate
- cdna
- recombinant
- inhibiting
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C07K14/38—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from Aspergillus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
- A61K47/6817—Toxins
- A61K47/6819—Plant toxins
- A61K47/6825—Ribosomal inhibitory proteins, i.e. RIP-I or RIP-II, e.g. Pap, gelonin or dianthin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Botany (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT96FI000155A IT1286663B1 (en) | 1996-06-27 | 1996-06-27 | PROTEIN CAPABLE OF INHIBITING RIBOSOMIAL ACTIVITY, ITS PREPARATION AND USE AS A CHEMICAL OR RECOMBINANT IMMUNOCONUGATE AND SEQUENCE OF CDNA |
PCT/EP1997/003359 WO1997049726A1 (en) | 1996-06-27 | 1997-06-26 | Recombinant ribosomal inhibitor protein (rip) and use as immunoconjugate |
AU34375/97A AU3437597A (en) | 1996-06-27 | 1997-06-26 | Recombinant ribosomal inhibitor protein (rip) and use as immunoconjugate |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT96FI000155A IT1286663B1 (en) | 1996-06-27 | 1996-06-27 | PROTEIN CAPABLE OF INHIBITING RIBOSOMIAL ACTIVITY, ITS PREPARATION AND USE AS A CHEMICAL OR RECOMBINANT IMMUNOCONUGATE AND SEQUENCE OF CDNA |
Publications (2)
Publication Number | Publication Date |
---|---|
ITFI960155A1 ITFI960155A1 (en) | 1997-12-27 |
IT1286663B1 true IT1286663B1 (en) | 1998-07-15 |
Family
ID=11351738
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT96FI000155A IT1286663B1 (en) | 1996-06-27 | 1996-06-27 | PROTEIN CAPABLE OF INHIBITING RIBOSOMIAL ACTIVITY, ITS PREPARATION AND USE AS A CHEMICAL OR RECOMBINANT IMMUNOCONUGATE AND SEQUENCE OF CDNA |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU3437597A (en) |
IT (1) | IT1286663B1 (en) |
WO (1) | WO1997049726A1 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6812327B1 (en) | 1996-10-25 | 2004-11-02 | Human Genome Sciences, Inc. | Neutrokine-alpha polypeptides |
DE19946142A1 (en) * | 1999-09-27 | 2001-03-29 | Bundesrepublik Deutschland Let | Cell-targeting vector selective for T lymphocytes, useful in gene therapy of e.g. acquired immune deficiency syndrome, encodes a single-chain variable antibody fragment |
AU6842701A (en) | 2000-06-16 | 2002-01-14 | Human Genome Sciences Inc | Antibodies that immunospecifically bind to blys |
EP1174506A1 (en) * | 2000-06-28 | 2002-01-23 | Stichting Dienst Landbouwkundig Onderzoek | C-terminal Erns peptide and analogues thereof |
US20030091565A1 (en) | 2000-08-18 | 2003-05-15 | Beltzer James P. | Binding polypeptides and methods based thereon |
JP2004533997A (en) | 2001-02-20 | 2004-11-11 | ザイモジェネティクス,インコーポレイティド | Antibodies that bind both BCMA and TACI |
EP1497415B1 (en) | 2002-04-19 | 2010-12-29 | ZymoGenetics, L.L.C. | Methods for detection or modulation of the interaction of a cytokine receptor with its ligand |
US9168286B2 (en) | 2005-10-13 | 2015-10-27 | Human Genome Sciences, Inc. | Methods and compositions for use in treatment of patients with autoantibody positive disease |
WO2007123765A2 (en) | 2006-03-31 | 2007-11-01 | Human Genome Sciences Inc. | Neutrokine-alpha and neutrokine-alpha splice variant |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE62463B1 (en) * | 1988-07-07 | 1995-02-08 | Res Dev Foundation | Immunoconjugates for cancer diagnosis and therapy |
JP2518732B2 (en) * | 1990-02-22 | 1996-07-31 | 株式会社大塚製薬工場 | α-sarcin gene |
KR920702229A (en) * | 1990-06-29 | 1992-09-03 | 마에다 카쯔노스케 | Immunotoxin complex |
AU654563B2 (en) * | 1991-07-24 | 1994-11-10 | Imperial Chemical Industries Plc | Proteins |
DK1136556T3 (en) * | 1991-11-25 | 2005-10-03 | Enzon Inc | Process for the preparation of multivalent antigen-binding proteins |
US5597569A (en) * | 1993-10-25 | 1997-01-28 | Bristol-Myers Squibb Company | Bryodin 2 a ribosome-inactivating protein isolated from the plant Bryonia dioica |
GB9324807D0 (en) * | 1993-12-03 | 1994-01-19 | Cancer Res Campaign Tech | Tumour antibody |
-
1996
- 1996-06-27 IT IT96FI000155A patent/IT1286663B1/en active IP Right Grant
-
1997
- 1997-06-26 AU AU34375/97A patent/AU3437597A/en not_active Abandoned
- 1997-06-26 WO PCT/EP1997/003359 patent/WO1997049726A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
AU3437597A (en) | 1998-01-14 |
ITFI960155A1 (en) | 1997-12-27 |
WO1997049726A1 (en) | 1997-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1019358E (en) | 3,3-DIARILPROPILLAMINES ITS USE AND PREPARATION | |
BR9504791B1 (en) | polypeptide compound and pharmaceutical composition. | |
BR9708400A (en) | Composition, preparation and use | |
DE69727572D1 (en) | AQUEOUS PEPTIDE PREPARATION | |
TR199501669A1 (en) | Aerosol formulations of peptide and proteins. | |
PL336889A1 (en) | Preparations of activated protein c | |
DE69530791D1 (en) | PROTEIN TYROSINE KINASE (PYK2), YOUR CDNA CLONING AND YOUR USE | |
EP1022286A4 (en) | POLYPEPTIDE, cDNA ENCODING THE POLYPEPTIDE, AND USE OF THE BOTH | |
BR9707501A (en) | Compound pharmaceutical composition and use of the compound | |
DK19991D0 (en) | PROTEIN PREPARATIONS | |
IL123647A0 (en) | Substituted amino compounds their preparation and use | |
BR9707812A (en) | Pharmaceutical Compound Compound and Compound Use | |
BR9707808A (en) | Compound pharmaceutical composition and use of the compound | |
IT1286663B1 (en) | PROTEIN CAPABLE OF INHIBITING RIBOSOMIAL ACTIVITY, ITS PREPARATION AND USE AS A CHEMICAL OR RECOMBINANT IMMUNOCONUGATE AND SEQUENCE OF CDNA | |
FI963334A (en) | Isolated peptides derived from tyrosinase and their use | |
BR9612413A (en) | Compound use of the same and pharmaceutical composition | |
ATE283706T1 (en) | ßPHARMACEUTICAL PREPARATIONS OF CILANSETRONß STABILIZED AGAINST RACEMIZATION | |
ID21034A (en) | KINASE PROTEINS AND ITS USE | |
EE9800275A (en) | Prolonged-release pharmaceutical preparations containing misolastin | |
FI972965A0 (en) | New peptides, their preparation and use | |
EP0841393A4 (en) | HUMAN GALECTIN-4-LIKE PROTEIN AND cDNA ENCODING THE SAME | |
EE9900092A (en) | PTX-sensitive G proteins, their preparation and use | |
NO177858C (en) | Peptide | |
NO20006091D0 (en) | Human protein C polypeptide | |
AU1867999A (en) | Lysozym-analogous proteins and peptide having an anti-microbial activity, production of the same and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
0001 | Granted |